Compared to Semaglutide and Tirzepatide, retatrutide's distinctive inclusion of glucagon receptor agonism together with GIP and GLP-1 receptor agonism offers a distinct pharmacological profile. While Semaglutide is often a GLP-1 receptor agonist and Tirzepatide brings together GLP-1 and GIP receptor agonism, retatrutide's triple mechanism could potentially present broader metabolic https://andrewr010rix9.westexwiki.com/user